Company · CIK 0001664710
Keros Therapeutics, Inc.
KROSSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$11.95+$0.31 (+2.66%)
KROS · Last trade
- Prev close
- $11.64
- Range (29d)
- $10.74 – $11.95
On the record
Recent filings
- 8-KKROSCurrent report0001664710-26-000059 · 167.3 KBSEC(opens sec.gov)
- 8-KKROSCurrent report0001664710-26-000056 · 169.5 KBSEC(opens sec.gov)
- 8-KKROSCurrent report0001664710-26-000053 · 164.7 KBSEC(opens sec.gov)
- 144KROSKeros Therapeutics, Inc.0001969223-26-000924 · 4.9 KBSEC(opens sec.gov)
- 8-KKROSCurrent report0001664710-26-000050 · 4.6 MBSEC(opens sec.gov)
- 10-QKROSQuarterly update0001664710-26-000049 · 6.1 MBSEC(opens sec.gov)
- 8-KKROSCurrent report0001664710-26-000048 · 256.9 KBSEC(opens sec.gov)
- 8-KKROSCurrent report0001664710-26-000043 · 169.8 KBSEC(opens sec.gov)
- SCHEDULE 13G/AKROSKeros Therapeutics, Inc.0002012383-26-002890 · 10.9 KBSEC(opens sec.gov)
- 8-KKROSCurrent report0001664710-26-000038 · 158.2 KBSEC(opens sec.gov)
Insiders
- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Arkin Bio Ventures Limited Partnership10% Owner
- Arkin Moshe10% Owner
- BIENAIME JEAN JACQUESDirector
- Cho EstherChief Legal Officer
- CHYUNG YUNG H.Chief Medical Officer
- Cooper Simon PeterCHIEF MEDICAL OFFICER
- Farzan NimaDirector
- GORDON CARL LDirector
Tickers
Addresses
business
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421
mailing
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421
Same industry